File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

서판길

Suh, Pann-Ghill
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

A novel non-agonist peroxisome proliferator-activated receptor γ (PPARγ) ligand UHC1 blocks PPARγ phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivity

Author(s)
Choi, Sun-SilKim, Eun SunKoh, MinseobLee, Soo-JinLim, DonghyunYang, Yong RyoulJang, Hyun-JunSeo, Kyung-ahMin, Sang-HyunLee, In HeePark, Seung BumSuh, Pann-GhillChoi, Jang Hyun
Issued Date
2014-09
DOI
10.1074/jbc.M114.566794
URI
https://scholarworks.unist.ac.kr/handle/201301/6901
Fulltext
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84907203364
Citation
JOURNAL OF BIOLOGICAL CHEMISTRY, v.289, no.38, pp.26618 - 26629
Abstract
Background: PPARβ ligands can be used in numerous metabolic syndromes. Results: A novel non-agonist PPARβ ligand, UHC1 exhibited great beneficial effects on glucose metabolism and anti-inflammatory response. Conclusion: UHC1 shows anti-diabetic action by blocking CDK5-mediated PPARβ phosphorylation. Significance: UHC1 can be a novel therapeutic agent for use in type 2 diabetes and related metabolic disorders.
Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
ISSN
0021-9258

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.